Omar Brahim

Omar Brahim serves as the Vice President of Financial Planning Analysis at Stoke Therapeutics since July 2025, bringing extensive experience in financial leadership from previous roles at Mersana Therapeutics as Vice President and Executive Director in FP&A, and at TESARO, Inc. as Director of Financial Planning & Analysis. With a strong foundation in financial management, Omar has directed financial forecasting, strategic analysis, and budgeting across various organizations including Novartis, iRobot, and Raytheon. Education includes a Master of Business Administration from the University of Massachusetts Lowell, complementing a robust career characterized by collaboration with executive leadership teams and expertise in compliance and government contracts management.